questionsmedicales.fr
Composés hétérocycliques
Composés hétéromonocycliques
Pyridines
Composés de pyridinium
Composés de pyridinium : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Intoxication
Tests sanguins
Analyse chromatographique
Spectrométrie
Nausées
Troubles neurologiques
Tests urinaires
Métabolites
Historique médical
Symptômes
Symptômes
5
Douleurs abdominales
Troubles respiratoires
Éruptions cutanées
Irritations
Évolution des symptômes
Intervention rapide
Prévention
5
Équipements de protection
Exposition
Formations
Sécurité chimique
Fuites
Protocoles de sécurité
Traitements
5
Décontamination
Antidotes
Soins de soutien
Hydratation
Surveillance
Complications
Complications
5
Lésions organiques
Troubles respiratoires
Effets à long terme
Troubles cognitifs
Prise en charge médicale
Suivi régulier
Intervention rapide
Traitement approprié
Difficultés respiratoires
Confusion mentale
Facteurs de risque
5
Travailleurs en chimie
Industrie
Jeunes enfants
Personnes âgées
Antécédents médicaux
Maladies respiratoires
Conditions environnementales
Chaleur
Interactions médicamenteuses
Toxicité
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Composés de pyridinium : Questions médicales les plus fréquentes",
"headline": "Composés de pyridinium : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Composés de pyridinium : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-05",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Composés de pyridinium"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Pyridines",
"url": "https://questionsmedicales.fr/mesh/D011725",
"about": {
"@type": "MedicalCondition",
"name": "Pyridines",
"code": {
"@type": "MedicalCode",
"code": "D011725",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cétylpyridinium",
"alternateName": "Cetylpyridinium",
"url": "https://questionsmedicales.fr/mesh/D002594",
"about": {
"@type": "MedicalCondition",
"name": "Cétylpyridinium",
"code": {
"@type": "MedicalCode",
"code": "D002594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.232"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Diquat",
"alternateName": "Diquat",
"url": "https://questionsmedicales.fr/mesh/D004178",
"about": {
"@type": "MedicalCondition",
"name": "Diquat",
"code": {
"@type": "MedicalCode",
"code": "D004178",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.352"
}
}
},
{
"@type": "MedicalWebPage",
"name": "1-Méthyl-4-phényl-pyridinium",
"alternateName": "1-Methyl-4-phenylpyridinium",
"url": "https://questionsmedicales.fr/mesh/D015655",
"about": {
"@type": "MedicalCondition",
"name": "1-Méthyl-4-phényl-pyridinium",
"code": {
"@type": "MedicalCode",
"code": "D015655",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.550"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chlorure d'obidoxime",
"alternateName": "Obidoxime Chloride",
"url": "https://questionsmedicales.fr/mesh/D009768",
"about": {
"@type": "MedicalCondition",
"name": "Chlorure d'obidoxime",
"code": {
"@type": "MedicalCode",
"code": "D009768",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.600"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Paraquat",
"alternateName": "Paraquat",
"url": "https://questionsmedicales.fr/mesh/D010269",
"about": {
"@type": "MedicalCondition",
"name": "Paraquat",
"code": {
"@type": "MedicalCode",
"code": "D010269",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.621"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Bromure de pyridostigmine",
"alternateName": "Pyridostigmine Bromide",
"url": "https://questionsmedicales.fr/mesh/D011729",
"about": {
"@type": "MedicalCondition",
"name": "Bromure de pyridostigmine",
"code": {
"@type": "MedicalCode",
"code": "D011729",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.740"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Trimédoxime",
"alternateName": "Trimedoxime",
"url": "https://questionsmedicales.fr/mesh/D014289",
"about": {
"@type": "MedicalCondition",
"name": "Trimédoxime",
"code": {
"@type": "MedicalCode",
"code": "D014289",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.900"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Viologènes",
"alternateName": "Viologens",
"url": "https://questionsmedicales.fr/mesh/D014755",
"about": {
"@type": "MedicalCondition",
"name": "Viologènes",
"code": {
"@type": "MedicalCode",
"code": "D014755",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.925"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Benzyl viologène",
"alternateName": "Benzyl Viologen",
"url": "https://questionsmedicales.fr/mesh/D001594",
"about": {
"@type": "MedicalCondition",
"name": "Benzyl viologène",
"code": {
"@type": "MedicalCode",
"code": "D001594",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D03.383.725.762.925.100"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Composés de pyridinium",
"alternateName": "Pyridinium Compounds",
"code": {
"@type": "MedicalCode",
"code": "D011726",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Sungwoo Hong",
"url": "https://questionsmedicales.fr/author/Sungwoo%20Hong",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr."
}
},
{
"@type": "Person",
"name": "Werner Fudickar",
"url": "https://questionsmedicales.fr/author/Werner%20Fudickar",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Potsdam, Potsdam, Germany."
}
},
{
"@type": "Person",
"name": "Torsten Linker",
"url": "https://questionsmedicales.fr/author/Torsten%20Linker",
"affiliation": {
"@type": "Organization",
"name": "Department of Chemistry, University of Potsdam, Potsdam, Germany."
}
},
{
"@type": "Person",
"name": "Lihua Luo",
"url": "https://questionsmedicales.fr/author/Lihua%20Luo",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China."
}
},
{
"@type": "Person",
"name": "Rui Sun",
"url": "https://questionsmedicales.fr/author/Rui%20Sun",
"affiliation": {
"@type": "Organization",
"name": "Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Offensive language detection in low resource languages: A use case of Persian language.",
"datePublished": "2024-06-21",
"url": "https://questionsmedicales.fr/article/38905214",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0304166"
}
},
{
"@type": "ScholarlyArticle",
"name": "Geography and language divergence: The case of Andic languages.",
"datePublished": "2022-05-26",
"url": "https://questionsmedicales.fr/article/35617249",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1371/journal.pone.0265460"
}
},
{
"@type": "ScholarlyArticle",
"name": "An investigation across 45 languages and 12 language families reveals a universal language network.",
"datePublished": "2022-07-18",
"url": "https://questionsmedicales.fr/article/35856094",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41593-022-01114-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Language Environment at Home of Children With (a Suspicion of) a Developmental Language Disorder and Relations With Standardized Language Measures.",
"datePublished": "2023-07-07",
"url": "https://questionsmedicales.fr/article/37418756",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1044/2023_JSLHR-23-00066"
}
},
{
"@type": "ScholarlyArticle",
"name": "Adaptive Language Mapping Paradigms for Presurgical Language Mapping.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36137653",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3174/ajnr.A7629"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Composés hétérocycliques",
"item": "https://questionsmedicales.fr/mesh/D006571"
},
{
"@type": "ListItem",
"position": 3,
"name": "Composés hétéromonocycliques",
"item": "https://questionsmedicales.fr/mesh/D006573"
},
{
"@type": "ListItem",
"position": 4,
"name": "Pyridines",
"item": "https://questionsmedicales.fr/mesh/D011725"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composés de pyridinium",
"item": "https://questionsmedicales.fr/mesh/D011726"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Composés de pyridinium - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Composés de pyridinium",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Composés de pyridinium",
"description": "Comment diagnostiquer une intoxication aux composés de pyridinium ?\nQuels tests sont utilisés pour détecter les composés de pyridinium ?\nQuels symptômes indiquent une exposition aux pyridiniums ?\nLes tests urinaires peuvent-ils détecter les pyridiniums ?\nQuelle est l'importance de l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Language#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Composés de pyridinium",
"description": "Quels sont les symptômes courants d'une exposition aux pyridiniums ?\nLes composés de pyridinium provoquent-ils des effets neurologiques ?\nY a-t-il des symptômes cutanés associés aux pyridiniums ?\nLes symptômes varient-ils selon le type de pyridinium ?\nComment les symptômes évoluent-ils avec le temps ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Language#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Composés de pyridinium",
"description": "Quelles mesures préventives peuvent réduire l'exposition aux pyridiniums ?\nLes formations sont-elles nécessaires pour manipuler des pyridiniums ?\nComment stocker les composés de pyridinium en toute sécurité ?\nLes fuites de pyridiniums peuvent-elles être évitées ?\nQuelles sont les recommandations pour les laboratoires ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Language#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Composés de pyridinium",
"description": "Quel est le traitement principal en cas d'intoxication aux pyridiniums ?\nLes soins de soutien sont-ils nécessaires pour les patients exposés ?\nQuels antidotes sont utilisés contre les pyridiniums ?\nLa dialyse est-elle efficace pour éliminer les pyridiniums ?\nComment prévenir les complications lors du traitement ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Language#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Composés de pyridinium",
"description": "Quelles complications peuvent survenir après une exposition aux pyridiniums ?\nLes effets à long terme des pyridiniums sont-ils connus ?\nComment les complications sont-elles gérées ?\nLes complications peuvent-elles être évitées ?\nQuels sont les signes d'alerte pour des complications graves ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Language#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Composés de pyridinium",
"description": "Quels sont les principaux facteurs de risque d'exposition aux pyridiniums ?\nL'âge influence-t-il la sensibilité aux pyridiniums ?\nLes antécédents médicaux augmentent-ils le risque d'intoxication ?\nLes conditions environnementales jouent-elles un rôle ?\nLes interactions médicamenteuses sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D011726?mesh_terms=Language#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux composés de pyridinium ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'historique d'exposition et des tests sanguins spécifiques."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les composés de pyridinium ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses chromatographiques et spectrométriques sont couramment utilisées."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une exposition aux pyridiniums ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des nausées, des vomissements et des troubles neurologiques."
}
},
{
"@type": "Question",
"name": "Les tests urinaires peuvent-ils détecter les pyridiniums ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains tests urinaires peuvent révéler la présence de métabolites pyridiniques."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique médical aide à établir un lien entre les symptômes et l'exposition aux pyridiniums."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants d'une exposition aux pyridiniums ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des vertiges et des troubles respiratoires."
}
},
{
"@type": "Question",
"name": "Les composés de pyridinium provoquent-ils des effets neurologiques ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent causer des maux de tête, des convulsions et des troubles de la conscience."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes cutanés associés aux pyridiniums ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées et des irritations peuvent survenir après contact avec ces composés."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type de pyridinium ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de la structure chimique et de la dose."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec le temps ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver sans traitement approprié, nécessitant une intervention rapide."
}
},
{
"@type": "Question",
"name": "Quelles mesures préventives peuvent réduire l'exposition aux pyridiniums ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des équipements de protection individuelle lors de la manipulation de ces composés."
}
},
{
"@type": "Question",
"name": "Les formations sont-elles nécessaires pour manipuler des pyridiniums ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des formations sur la sécurité chimique sont essentielles pour les travailleurs exposés."
}
},
{
"@type": "Question",
"name": "Comment stocker les composés de pyridinium en toute sécurité ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les stocker dans des contenants hermétiques et étiquetés, à l'écart des sources de chaleur."
}
},
{
"@type": "Question",
"name": "Les fuites de pyridiniums peuvent-elles être évitées ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, en vérifiant régulièrement les équipements et en respectant les protocoles de sécurité."
}
},
{
"@type": "Question",
"name": "Quelles sont les recommandations pour les laboratoires ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les laboratoires doivent suivre des protocoles stricts de manipulation et de stockage des pyridiniums."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal en cas d'intoxication aux pyridiniums ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est la décontamination et l'administration d'antidotes spécifiques."
}
},
{
"@type": "Question",
"name": "Les soins de soutien sont-ils nécessaires pour les patients exposés ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des soins de soutien, comme l'hydratation et la surveillance, sont souvent requis."
}
},
{
"@type": "Question",
"name": "Quels antidotes sont utilisés contre les pyridiniums ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antidotes comme l'atropine peuvent être administrés pour contrer les effets toxiques."
}
},
{
"@type": "Question",
"name": "La dialyse est-elle efficace pour éliminer les pyridiniums ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La dialyse peut être envisagée dans les cas graves d'intoxication pour éliminer les toxines."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications lors du traitement ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance étroite et un traitement rapide des symptômes sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une exposition aux pyridiniums ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme des lésions organiques, des troubles neurologiques et respiratoires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les effets à long terme des pyridiniums sont-ils connus ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets à long terme incluent des troubles cognitifs et des problèmes respiratoires chroniques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications nécessitent une prise en charge médicale spécialisée et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être évitées ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une intervention rapide et un traitement approprié peuvent réduire le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'alerte pour des complications graves ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des signes comme des difficultés respiratoires, des convulsions ou une confusion mentale doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque d'exposition aux pyridiniums ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les travailleurs en chimie, agriculture et industrie sont les plus exposés aux pyridiniums."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il la sensibilité aux pyridiniums ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus sensibles aux effets toxiques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux augmentent-ils le risque d'intoxication ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents de maladies respiratoires ou neurologiques peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les conditions environnementales jouent-elles un rôle ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des conditions comme la chaleur ou l'humidité peuvent exacerber les effets des pyridiniums."
}
},
{
"@type": "Question",
"name": "Les interactions médicamenteuses sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines interactions médicamenteuses peuvent augmenter la toxicité des pyridiniums."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 31/03/2025
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr.
Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS) Daejeon 34141 Korea.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Potsdam, Potsdam, Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, University of Potsdam, Potsdam, Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Xi'an Medical University, Xi'an, Shaanxi 710021, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Green Chemistry and Technology, Ministry of Education, College of Chemistry, Sichuan University, Chengdu, Sichuan 610064, P. R. China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry, Korea Advanced Institute of Science and Technology (KAIST) Daejeon 34141 Korea hongorg@kaist.ac.kr.
Center for Catalytic Hydrocarbon Functionalizations, Institute for Basic Science (IBS) Daejeon 34141 Korea.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Georg-August Universität Göttingen , Tammannstraße 2 , 37077 Göttingen , Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Georg-August Universität Göttingen , Tammannstraße 2 , 37077 Göttingen , Germany.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Key Laboratory of Applied Surface and Colloid Chemistry, Ministry of Education and School of Chemistry and Chemical Engineering, Shaanxi Normal University, Xi'an 710119, China.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Pediatrics, Carver College of Medicine, University of Iowa, Iowa City, Iowa, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Chemistry and Biochemistry, Northern Illinois University, DeKalb, Illinois, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
2 publications dans cette catégorie
Affiliations :
Department of Medicine, Section of Infectious Disease, University of Wisconsin, Madison, Wisconsin, USA.
Department of Medical Microbiology and Immunology, University of Wisconsin, Madison Wisconsin, USA.
Publications dans "Composés de pyridinium" :
THIS ARTICLE USES WORDS OR LANGUAGE THAT IS CONSIDERED PROFANE, VULGAR, OR OFFENSIVE BY SOME READERS. Different types of abusive content such as offensive language, hate speech, aggression, etc. have ...
We study the correlation between phylogenetic and geographic distances for the languages of the Andic branch of the East Caucasian (Nakh-Daghestanian) language family. For several alternative phylogen...
To understand the architecture of human language, it is critical to examine diverse languages; however, most cognitive neuroscience research has focused on only a handful of primarily Indo-European la...
This study compares the home language environments of children with (a suspicion of) developmental language disorder (DLD) with that of children with typical development (TD). It does so by adopting n...
Ninety-nine 2- to 4-year-old toddlers participated: 59 with (a suspicion of) DLD and 40 with TD. LENA metrics on adult word count, conversational turn count, and child vocalization count were obtained...
We found lower adult word count, conversational turn count, and child vocalization count in the DLD group, independent of multilingualism but not of parental education. In the DLD group, receptive voc...
Toddlers with (a suspicion of) DLD vocalize less at home than children with TD. They also hear fewer adult words and experience fewer conversational turns. Children with DLD's language outcomes are to...
Functional MR imaging is widely used for preoperative language assessment in candidates for resective neurosurgery. Language mapping paradigms that are adaptive to participant performance have the pot...
Seventy-three patients undergoing fMRI for language lateralization and/or localization completed an adaptive semantic matching paradigm, an adaptive phonological judgment paradigm, and two standard pa...
The adaptive semantic paradigm resulted in the most strongly lateralized activation maps, the greatest extent of frontal and temporal activations, and the greatest proportion of overall satisfactory l...
The adaptive language mapping paradigms investigated have several psychometric advantages compared with currently recommended paradigms. Adoption of these paradigms could increase the likelihood of ob...
Life expectancy has been increasing in recent decades. Therefore, it is important to understand the functional changes during healthy ageing. Most research has mainly focused on one linguistic domain ...
Twenty-three older healthy Hebrew-speaking adults, exhibiting no cognitive decline, were examined on tasks aimed at testing their performance in different language and cognitive domains: lexical retri...
A decline was found in several linguistic domains among the older adults, while in other domains no decline was found. However, no unequivocal decline in linguistic functioning was found due to relati...
Not all linguistic domains are equally vulnerable in ageing, and not all older adults are equally affected. The research has both clinical and theoretical implications....
Recent research suggests that speaking a tone language confers benefits in processing pitch in nonlinguistic contexts such as music. This research largely compares speakers of nontone European languag...
Speech-language pathologists (SLPs) have multiple roles and responsibilities related to language and literacy instruction in schools. The purpose of this exploratory, qualitative study was to analyze ...
Eight school-based SLPs participated in a 1-hr virtual focus group conducted via Zoom recording technology. The researchers used a conventional content analysis approach to analyze the focus group dat...
The researchers developed two themes: (a) SLPs identified repeated exposure to books, peer interaction, and teaching vocabulary with visual supports and props as key elements of language and literacy ...
SLPs identified several instructional practices inclusive pre-K teachers could be taught to use during professional development programs to support the emergent literacy development of children with D...
What language devises, it might divide. By exploring the relations among the core geometries of the physical world, the abstract geometry of Euclid, and language, I give new insight into both the pers...
Consequences of multilingualism vary from offering cognitive benefits to poor educational and cognitive outcomes. One aspect of multilingualism that has not been systematically examined is the typolog...